Literature DB >> 32750292

Biomechanics of Aortic Dissection: A Comparison of Aortas Associated With Bicuspid and Tricuspid Aortic Valves.

Jennifer C-Y Chung1, Edwin Wong2,3, Mingyi Tang2,3, Daniella Eliathamby1, Thomas L Forbes4, Jagdish Butany5, Craig A Simmons2,3,6, Maral Ouzounian1.   

Abstract

Background Current methods for aortic dissection risk assessment are inadequate for patients with ascending aortic aneurysms associated with either bicuspid aortic valves (BAVs) or tricuspid aortic valves (TAVs). Biomechanical testing of aortic tissue may provide novel insights and biomarkers. Methods and Results From March 2017 to August 2019, aneurysmal ascending aortas (BAV=23, TAV=23) were collected from elective aortic surgery, normal aortas from transplant donors (n=9), and dissected aortas from surgery for aortic dissection (n=7). These aortas underwent delamination testing in simulation of aortic dissection. Biaxial tensile testing was performed to determine modulus of elasticity (aortic stiffness), and energy loss (a measure of efficiency in performing the Windkessel function). Delamination strength (Sd) was lowest in dissected aortas (18±6 mN/mm) and highest in normal aortas (58±16 mN/mm), and aneurysms fell in between, with greater Sd in the BAV group (37±10 mN/mm) than the TAV group (27±10 mN/mm) (P<0.001). Bicuspid aortopathy was associated with greater stiffness (P<0.001), while aneurysms with TAV demonstrated greater energy loss (P<0.001). Sd decreased by 7.8±1.2 mmol/L per mm per decade of life (r2=0.45, P<0.001), and it was significantly lower for patients with hypertension (P=0.001). Sd decreased by 6.1±2.1 mmol/L per mm with each centimeter increase in aortic diameter (r2=0.15, P=0.007). Increased energy loss was associated with decreased Sd (r2=0.41), whereas there was no relationship between Sd and aortic stiffness. Conclusions Aneurysms with BAV had higher Sd than those with TAV, suggesting that BAV was protective. Energy loss was lower in aneurysms with BAV, and inversely associated with Sd, representing a potential novel biomarker.

Entities:  

Keywords:  aortic aneurysm; aortic dissection; bicuspid aortic valve; biomechanics

Year:  2020        PMID: 32750292     DOI: 10.1161/JAHA.120.016715

Source DB:  PubMed          Journal:  J Am Heart Assoc        ISSN: 2047-9980            Impact factor:   5.501


  6 in total

1.  Gender differences in the dissection properties of ascending thoracic aortic aneurysms.

Authors:  Jianhua Tong; Mieradilijiang Abudupataer; Xiaojuan Xu; Zhi Zhang; Jun Li; Hao Lai; Chunsheng Wang; Kai Zhu
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-07-09

2.  Reply from authors: Toward physiologically meaningful biomechanical parameters from ex vivo biaxial testing.

Authors:  Miriam Nightingale; Taisiya Sigaeva; Elena S Di Martino
Journal:  JTCVS Open       Date:  2022-05-10

3.  Microcalcification and Thoracic Aortopathy: A Window Into Disease Severity.

Authors:  Alexander J Fletcher; Jennifer Nash; Maaz B J Syed; Mark G Macaskill; Adriana A S Tavares; Niki Walker; Hannah Salcudean; Jonathon A Leipsic; Kelvin H H Lim; Jillian Madine; William Wallace; Mark Field; David E Newby; Rihab Bouchareb; Michael A Seidman; Riaz Akhtar; Stephanie L Sellers
Journal:  Arterioscler Thromb Vasc Biol       Date:  2022-06-30       Impact factor: 10.514

4.  Searching for a physiologically meaningful parameter for aortic biomechanics-is energy loss the way?

Authors:  Mingyi Tang; Craig A Simmons; Jennifer C-Y Chung
Journal:  JTCVS Open       Date:  2022-04-13

Review 5.  Clinical implications of the biomechanics of bicuspid aortic valve and bicuspid aortopathy.

Authors:  Ali Fatehi Hassanabad; Melissa A King; Elena Di Martino; Paul W M Fedak; Julio Garcia
Journal:  Front Cardiovasc Med       Date:  2022-08-12

6.  Should We Operate on Thoracic Aortic Aneurysm of 5-5.5cm in Bicuspid Aortic Valve Disease Patients?

Authors:  Katelyn Monaghan; Felix Orelaru; Aroma Naeem; Rana-Armaghan Ahmad; Xiaoting Wu; Karen M Kim; Shinichi Fukuhara; Himanshu J Patel; G Michael Deeb; Bo Yang
Journal:  Cardiol Cardiovasc Med       Date:  2021-12-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.